In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopahy

Cagnin, A.; Taylor-Robinson, S. D.; Forton, D. M.; Banati, R. B.
April 2006
Gut;Apr2006, Vol. 55 Issue 4, p547
Academic Journal
Background and aim: One proposed mechanism whereby hepatic encephalopathy (HE) leads to loss of brain function is dysregulated synthesis of neurosteroids. Mitochondrial synthesis of neurosteroids is regulated by "peripheral benzodiazepine binding sites" (PBBS). Expressed in the brain by activated glial cells, PBBS can be measured in vivo by the specific ligand [11C](R)-PK11195 and positron emission tomography (PET). Recently, it has been suggested that PBBS expressing glial cells may play a role in the general inflammatory responses seen in HE. Therefore, we measured PBBS in vivo in the brains of patients with minimal HE using [11C](R)-PK11195 PET. Methods: Five patients with minimal HE and biopsy proven cirrhosis of differing aetiology were assessed with a neuropsychometric battery. Regional expression of PBBS in the brain was detected by [11C](R)-PK11195 PET. Results: All patients showed brain regions with increased [11C](R)-PK11195 binding. Significant increases in glial [11C](R)-PK11195 binding were found bilaterally in the pallidum, right putamen, and right dorsolateral prefrontal region. The patient with the most severe cognitive impairment had the highest increases in regional [11C](R)-PK11195 binding. Conclusion: HE is associated with increased cerebral binding of [11C](R)-PK11195 in vivo, reflecting increased expression of PBBS by glial cells. This supports earlier experimental evidence in rodent models of liver failure, suggesting that an altered glial cell state, as evidenced by the increase in cerebral PBBS, might be causally related to impaired brain functioning in HE.


Related Articles

  • Binding of NIR-conPK and NIR-6T to Astrocytomas and Microglial Cells: Evidence for a Protein Related to TSPO. Sexton, Michelle; Woodruff, Grace; Cudaback, Eiron; Kreitzer, Faith R.; Cong Xu; Yi Hsing Lin; Möller, Thomas; Mingfeng Bai; Charles Manning, H.; Bornhop, Darryl; Stella, Nephi // PLoS ONE;2009, Vol. 4 Issue 12, p1 

    PK 11195 and DAA1106 bind with high-affinity to the translocator protein (TSPO, formerly known as the peripheral benzodiazepine receptor). TSPO expression in glial cells increases in response to cytokines and pathological stimuli. Accordingly, [11C]-PK 11195 and [11C]-DAA1106 are recognized...

  • Binding thermodynamics of a glutamate transporter homolog. Reyes, Nicolas; Oh, SeCheol; Boudker, Olga // Nature Structural & Molecular Biology;May2013, Vol. 20 Issue 5, p634 

    Glutamate transporters catalyze concentrative uptake of the neurotransmitter into glial cells and neurons. Their transport cycle involves binding and release of the substrate on the extra- and intracellular sides of the plasma membranes and translocation of the substrate-binding site across the...

  • Acetylcholinesterase Imaging: Its Use in Therapy Evaluation and Drug Design. Shinotoh, Hitoshi; Fukushi, Kiyoshi; Nagatsuka, Shin-Ichiro; Irie, Toshiaki // Current Pharmaceutical Design;May2004, Vol. 10 Issue 13, p1505 

    Several cholinesterase (ChE) inhibitors have been labeled with carbon-11 for visualizing binding sites on acetylcholinesterase (AChE) by positron emission tomography (PET). Following intravenous injection of 1,2,3,4-tetrahydro-9-[11C]methylaminoacridine or [11C]donepezil, however, the...

  • Relationship between In Vivo Receptor Occupancy and Efficacy of Metabotropic Glutamate Receptor Subtype 5 Allosteric Modulators with Different In Vitro Binding Profiles. Rook, Jerri M; Tantawy, Mohammed N; Ansari, Mohammad S; Felts, Andrew S; Stauffer, Shaun R; Emmitte, Kyle A; Kessler, Robert M; Niswender, Colleen M; Daniels, J Scott; Jones, Carrie K; Lindsley, Craig W; Conn, P Jeffrey // Neuropsychopharmacology;Feb2015, Vol. 40 Issue 3, p755 

    Allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGlu5) have exciting potential as therapeutic agents for multiple brain disorders. Translational studies with mGlu5 modulators have relied on mGlu5 allosteric site positron emission tomography (PET) radioligands to assess...

  • Uridine Function in the Central Nervous System. Dobolyi, Arp�d; Juh�sz, G�bor; Kov�cs, Zsolt; Kardos, Julianna // Current Topics in Medicinal Chemistry;Apr2011, Vol. 11 Issue 8, p1058 

    In the adult nervous system, the major source of nucleotide synthesis is the salvage pathway. Uridine is the major form of pyrimidine nucleosides taken up by the brain. Uridine is phosphorylated to nucleotides, which are used for DNA and RNA synthesis as well as for the synthesis of membrane...

  • Modulation of synaptic GABAA receptor function by zolpidem in substantia nigra pars reticulata. Li-Li Zhang; Lei Chen; Yan Xue; Wing-Ho Yung // Acta Pharmacologica Sinica;Feb2008, Vol. 29 Issue 2, p161 

    Aim: The substantia nigra pars reticulata (SNr) constitutes one of the output centers of the basal ganglia, and its abnormal activity is believed to contribute to some basal ganglia motor disorders. Different lines of evidence revealed a major contribution of GABAA receptor-mediated synaptic...

  • 3-Arylisothiazoloquinols as potent ligands for the benzodiazepine site of GABAA receptors. Nilsson, Jakob; Nielsen, Elsebet Østergaard; Liljefors, Tommy; Nielsen, Mogens; Sterner, Olov // Journal of Biomedical Science & Engineering;Jan2012, Vol. 5 Issue 1, p1 

    3-Arylisothiazolo[5,4-b]quinolin-4(9H)-ones and 3-arylisoxazolo[ 5,4-b]quinolin-4(9H)-ones were synthesized and assayed for affinity for the benzodiazepine binding site of the GABAA receptors. While the 3-arylisothiazoloquinolin- 4-ones were found to be potent ligands, with affinities (expressed...

  • Lack of generalisation between the GABAA receptor agonist, gaboxadol, and allosteric modulators of the benzodiazepine binding site in the rat drug discrimination procedure. Michelsen, Signe; Sánchez, Connie; Ebert, Bjarke // Psychopharmacology;Jul2007, Vol. 193 Issue 1, p151 

    The binding sites for γ-aminobutyric acid (GABA) and GABAA receptor agonists are located differently from the binding sites for benzodiazepine receptor agonists. Furthermore, the major pharmacological effects of benzodiazepine receptor agonists and the GABAA receptor agonist gaboxadol...

  • Automated in silico modelling and docking of ligands on benzodiazepine binding site of GABAA receptors. Vaishnav, Gajanan; G. K., Kulkarni; Sankar, S. // Journal of Pharmacy Research;Sep2011, Vol. 4 Issue 9, p3162 

    Many antianxiety, sedative and antiepileptic ligands such as benzodiazepines (BZDs) act by allosteric modulation of the GABA(A) receptor via the benzodiazepine binding site. This increases the affinity of GABA for the receptors. The exact mode of docking of these ligands in the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics